Royalty Pharma RPRX
NASDAQ RPRX
$57.16 -0.47 (-0.82%)
At close: Oct 2, 2026 · 4:00 PM EDT

Royalty Pharma (RPRX) Income towards Parent Company (2019 - 2026)

Updated

Royalty Pharma (RPRX) recorded Income towards Parent Company of $17.88 million in Q2 2026, down 44.4% from $32.18 million a year earlier and down 93.9% from the prior quarter.

Analysis

Royalty Pharma (RPRX) Income towards Parent Company (2019 - 2026) Analysis & Trends

On a TTM basis, Royalty Pharma's Income towards Parent Company came in at $815 million as of Jun 30, 2026, down 20.4% year-over-year; for FY2025, it was $770.95 million, down 10.2% from FY2024.

  • Annual Income towards Parent Company has a five-year compound annual growth rate of -4.6% (FY2020 to FY2025).
  • Across earlier years, Income towards Parent Company came in at $858.98 million in FY2024 (-24.3%), $1.13 billion in FY2023, $42.83 million in FY2022 (-93.1%) and $619.73 million in FY2021 (-36.4%).
  • The Q2 2026 figure is the lowest quarterly Income towards Parent Company since Q1 2024.
  • On a year-over-year basis, Income towards Parent Company rose in three of the last seven quarters, with growth averaging 66.1%.
  • Peak year-over-year performance for Income towards Parent Company in the last five years was growth of 654.3% in Q3 2024, against a decline of 98.6% in Q1 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $294.69 million (Q1 2026), $214.21 million (Q4 2025) and $288.22 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Rocket Companies 43.94 Bn 29.62 Bn -
2 Orix 41.70 Bn 42.20 Bn -
3 Royalty Pharma 32.87 Bn 32.78 Bn -
4 Federal National Mortgage Association Fannie Mae 25.52 Bn 25.52 Bn -
5 Affirm Holdings 23.86 Bn 17.55 Bn -
6 Synchrony Financial 23.33 Bn -44.64 Bn -
7 Royal Gold 19.87 Bn 19.09 Bn 390.45 Mn
8 Annaly Capital Management 13.89 Bn 4.98 Bn -
9 Ares Capital 13.54 Bn 10.98 Bn -
10 Federal Home Loan Mortgage 13.00 Bn -5.74 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.88 Mn
Mar 31, 2026 294.69 Mn
Dec 31, 2025 214.21 Mn
Sep 30, 2025 288.22 Mn
Jun 30, 2025 32.18 Mn
Mar 31, 2025 239.35 Mn
Dec 31, 2024 208.21 Mn
Sep 30, 2024 543.99 Mn
Jun 30, 2024 102.00 Mn
Mar 31, 2024 4.78 Mn
Dec 31, 2023 494.34 Mn
Sep 30, 2023 72.11 Mn
Jun 30, 2023 227.63 Mn
Mar 31, 2023 340.76 Mn
Dec 31, 2022 -456.08 Mn
Sep 30, 2022 142.65 Mn
Jun 30, 2022 304.50 Mn
Mar 31, 2022 51.76 Mn
Dec 31, 2021 7.90 Mn
Sep 30, 2021 101.93 Mn
API Access

Royalty Pharma Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=RPRX&period=max&api_key=YOUR_API_KEY